Authors:
Heinonen, H
Volin, L
Uutela, A
Zevon, M
Barrick, C
Ruutu, T
Citation: H. Heinonen et al., Quality of life and factors related to perceived satisfaction with qualityof life after allogeneic bone marrow transplantation, ANN HEMATOL, 80(3), 2001, pp. 137-143
Authors:
Jantunen, R
Juvonen, E
Ikkala, E
Oksanen, K
Anttila, P
Ruutu, T
Citation: R. Jantunen et al., The predictive value of vascular risk factors and gender for the development of thrombotic complications in essential thrombocythemia, ANN HEMATOL, 80(2), 2001, pp. 74-78
Authors:
Parkkali, T
Vakevainen, M
Kayhty, H
Ruutu, T
Ruutu, P
Citation: T. Parkkali et al., Opsonophagocytic activity against Streptococcus pneumoniae type 19F in allogeneic BMT recipients before and after vaccination with pneumococcal polysaccharide vaccine, BONE MAR TR, 27(2), 2001, pp. 207-211
Authors:
Parkkali, T
Kayhty, H
Lehtonen, H
Ruutu, T
Volin, L
Eskola, J
Ruutu, P
Citation: T. Parkkali et al., Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients, BONE MAR TR, 27(1), 2001, pp. 79-84
Authors:
Socie, G
Clift, RA
Blaise, D
Devergie, A
Ringden, O
Martin, PJ
Remberger, M
Deeg, HJ
Ruutu, T
Michallet, M
Sullivan, KM
Chevret, S
Citation: G. Socie et al., Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies, BLOOD, 98(13), 2001, pp. 3569-3574
Authors:
Oivanen, T
Ala-Harja, K
Almqvist, A
Apajalahti, J
Elonen, E
Hallman, H
Hanninen, A
Ilvonen, M
Isomaa, B
Jouppila, J
Jarvenpaa, E
Jarventie, G
Kilpi, H
Koistinen, P
Koistinen, S
Koivisto, AM
Koivunen, E
Korpi, E
Katka, K
Kaariainen, M
Lahtinen, R
Laitinen, A
Lehtinen, M
Makela, H
Nylanden, P
Nyman, D
Palva, I
Pelliniemi, TT
Pulli, T
Rajamaki, A
Rauhala, A
Remes, K
Rosengard, S
Ruutu, T
Soininen, K
Tiilikainen, J
Timonen, T
Waris, E
Vilpo, J
Volin, L
Citation: T. Oivanen et al., Acute leukaemia and other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study, EUR J HAEMA, 65(2), 2000, pp. 123-127
Authors:
Jantunen, E
Ruutu, P
Piilonen, A
Volin, L
Parkkali, T
Ruutu, T
Citation: E. Jantunen et al., Treatment and outcome of invasive Aspergillus infections in allogeneic BMTrecipients, BONE MAR TR, 26(7), 2000, pp. 759-762
Authors:
Jantunen, E
Piilonen, A
Volin, L
Parkkali, T
Koukila-Kahkola, P
Ruutu, T
Ruutu, P
Citation: E. Jantunen et al., Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients, BONE MAR TR, 25(8), 2000, pp. 867-871
Authors:
Frassoni, F
Labopin, M
Powles, R
Mary, JY
Arcese, W
Bacigalupo, A
Bunjes, D
Gluckman, E
Ruutu, T
Schaefer, UW
Sierra, J
Vernant, JP
Willemze, R
de Witte, T
Gorin, NC
Citation: F. Frassoni et al., Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia, LANCET, 355(9213), 2000, pp. 1393-1398
Authors:
Kourlas, PJ
Strout, MP
Becknell, B
Veronese, ML
Croce, CM
Theil, KS
Krahe, R
Ruutu, T
Knuutila, S
Bloomfield, CD
Caligiuri, MA
Citation: Pj. Kourlas et al., Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: Evidence for its fusion with MLL in acute myeloid leukemia, P NAS US, 97(5), 2000, pp. 2145-2150
Authors:
de Witte, T
Hermans, J
Vossen, J
Bacigalupo, A
Meloni, G
Jacobsen, N
Ruutu, T
Ljungman, P
Gratwohl, A
Runde, V
Niederwieser, D
van Biezen, A
Devergie, A
Cornelissen, J
Jouet, JP
Arnold, R
Apperley, J
Citation: T. De Witte et al., Haematopoietic stem cell transplantation for patients with myelodysplasticsyndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT), BR J HAEM, 110(3), 2000, pp. 620-630
Authors:
Ruutu, T
Volin, L
Parkkali, T
Juvonen, E
Elonen, E
Citation: T. Ruutu et al., Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study, BLOOD, 96(7), 2000, pp. 2391-2398
Authors:
Parkkali, T
Kayhty, H
Antilla, M
Ruutu, T
Wuorimaa, T
Soininen, A
Volin, L
Ruutu, P
Citation: T. Parkkali et al., IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines, BONE MAR TR, 24(6), 1999, pp. 671-678
Authors:
Valimaki, MJ
Kinnunen, K
Volin, L
Tahtela, R
Loyttyniemi, E
Laitinen, K
Makela, P
Keto, P
Ruutu, T
Citation: Mj. Valimaki et al., A prospective study of bone loss and turnover after allogeneic bone marrowtransplantation: effect of calcium supplementation with or without calcitonin, BONE MAR TR, 23(4), 1999, pp. 355-361
Authors:
Juvonen, E
Aimolahti, A
Volin, L
Ruutu, T
Citation: E. Juvonen et al., The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes, LEUK RES, 23(10), 1999, pp. 889-894
Authors:
Oivanen, T
Ala-Harja, K
Almqvist, A
Apajalahti, J
Elonen, E
Hallman, H
Hanninen, A
Ilvonen, M
Isomaa, B
Jouppila, J
Jarvenpaa, E
Jarventie, G
Kilpi, H
Koistinen, P
Koistinen, S
Koivisto, AM
Koivunen, E
Korpi, E
Katka, K
Kaariainen, M
Lahtinen, R
Laitinen, A
Lehtinen, M
Makela, H
Nylanden, P
Nyman, D
Palva, I
Pelliniemi, TT
Pulli, T
Rajamaki, A
Rauhala, A
Remes, K
Rosengard, S
Ruutu, T
Soininen, K
Tiilikainen, J
Timonen, T
Waris, E
Vilpo, J
Volin, L
Citation: T. Oivanen et al., Long-term survival in multiple myeloma: a Finnish Leukaemia Group study, BR J HAEM, 105(4), 1999, pp. 942-947
Authors:
Ringden, O
Remberger, M
Ruutu, T
Nikoskelainen, J
Volin, L
Vindelov, L
Parkkali, T
Lenhoff, S
Sallerfors, B
Mellander, L
Ljungman, P
Jacobsen, N
Citation: O. Ringden et al., Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: Long-term results of a randomized trial in allogeneic marrow recipients with leukemia, BLOOD, 93(7), 1999, pp. 2196-2201